EcoDrugPlus

Casein Kinase 2 Alpha 1

Ensembl ID : ENSBBBG00000001637
Gene Symbol: CSNK2A1
2 Cross references
138 Possible Orthologues:

Caspase 8

Ensembl ID : ENSBBBG00000012853
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSBBBG00000003489
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Caspase-1-Like

Ensembl ID : ENSBBBG00000022310
Gene Symbol: LOC104982832
2 Cross references
460 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSBBBG00000022211
Gene Symbol: COMT
3 Cross references
277 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSBBBG00000004145
Gene Symbol: CTSC
3 Cross references
235 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBBBG00000006256
Gene Symbol: CTSK
3 Cross references
246 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSBBBG00000024064
Gene Symbol: CTSS
3 Cross references
270 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSBBBG00000008125
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSBBBG00000002011
Gene Symbol: CHEK1
3 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSBBBG00000010816
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSBBBG00000000817
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).